ALUR Stock Summary and Trading Ideas (Allurion Technologies | NYSE:ALUR)

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies trades on the NYSE stock market under the symbol ALUR.

As of July 26, 2024, ALUR stock price declined to $0.86 with 151,865 million shares trading.

ALUR has a beta of 2.39, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.04 to the broad based SPY ETF.

ALUR has a market cap of $55.27 million. This is considered a Micro Cap stock.

Last quarter Allurion Technologies reported $9 million in Revenue and $.11 earnings per share. This beat revenue expectation by $186,000 and exceeded earnings estimates by $.41.

The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VXF, IWC.

ALUR support price is $.79 and resistance is $.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR stock will trade within this expected range on the day.